Development of human monoclonal antibodies against SARS-CoV-2
SARS-CoV-2 is the pathogen responsible for the COVID-19 pandemic, affecting more than 131 million individuals, including 2.8 million deaths. To combat the pandemic, rapid antigen diagnostic kits have been proposed to be a solution for managing the pandemic whilst enabling a continuous economy, as th...
Saved in:
Main Author: | Wong, Joel Xu En |
---|---|
Other Authors: | - |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/148643 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Examining the immunoreactivities of the receptor-binding domain of SARS-CoV-2 spike proteins using a panel of human monoclonal antibodies
by: Tan, Jie Ling
Published: (2022) -
Interaction of SARS-CoV spike protein with lipid rafts of host cells during viral entry
by: Lu, Yanning
Published: (2008) -
Characterization of monoclonal antibody specificities against conformational epitopes of dengue NS1 glycoprotein.
by: Cheng, Wei.
Published: (2009) -
Development of SARS-COV therapeutics using quaternary protein mimetics
by: Neo, Tuan Ling
Published: (2010) -
Study of sars-cov entry mechanism and development of protein mimetic inhibitors
by: Ji, Zhe
Published: (2011)